157 related articles for article (PubMed ID: 22435351)
21. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
Efron D; Jarman F; Barker M
Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
[TBL] [Abstract][Full Text] [Related]
22. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
Boellner SW; Earl CQ; Arora S
Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
[TBL] [Abstract][Full Text] [Related]
23. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
[TBL] [Abstract][Full Text] [Related]
24. Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
Findling RL; Greenhill LL; McNamara NK; Demeter CA; Kotler LA; O'Riordan MA; Myers C; Reed MD
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):433-45. PubMed ID: 17822339
[TBL] [Abstract][Full Text] [Related]
25. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
[TBL] [Abstract][Full Text] [Related]
26. Novel treatments for attention-deficit/hyperactivity disorder in children.
Spencer TJ; Biederman J; Wilens TE; Faraone SV
J Clin Psychiatry; 2002; 63 Suppl 12():16-22. PubMed ID: 12562057
[TBL] [Abstract][Full Text] [Related]
27. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.
Gucuyener K; Erdemoglu AK; Senol S; Serdaroglu A; Soysal S; Kockar AI
J Child Neurol; 2003 Feb; 18(2):109-12. PubMed ID: 12693777
[TBL] [Abstract][Full Text] [Related]
28. High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.
Pearson DA; Aman MG; Arnold LE; Lane DM; Loveland KA; Santos CW; Casat CD; Mansour R; Jerger SW; Ezzell S; Factor P; Vanwoerden S; Ye E; Narain P; Cleveland LA
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):284-91. PubMed ID: 22849541
[TBL] [Abstract][Full Text] [Related]
29. Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled, trial.
Shakibaei F; Radmanesh M; Salari E; Mahaki B
Complement Ther Clin Pract; 2015 May; 21(2):61-7. PubMed ID: 25925875
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.
He S; Wang M; Si J; Zhang T; Cui H; Gao X
BMJ Open; 2018 Feb; 8(2):e020434. PubMed ID: 29463592
[TBL] [Abstract][Full Text] [Related]
31. Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression.
Jeong HG; Ko YH; Oh SY; Han C; Kim T; Joe SH
Asia Pac Psychiatry; 2015 Sep; 7(3):330-6. PubMed ID: 25504813
[TBL] [Abstract][Full Text] [Related]
32. Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
Popper CW
J Clin Psychiatry; 1997; 58 Suppl 14():14-29; discussion 30-1. PubMed ID: 9418743
[TBL] [Abstract][Full Text] [Related]
33. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
[TBL] [Abstract][Full Text] [Related]
34. Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
Chronis-Tuscano A; French W; Strickland J; Sasser T; Gonzalez ENS; Whitlock KB; Stein MA
J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926603
[TBL] [Abstract][Full Text] [Related]
35. Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
Findling RL; Adler LA; Spencer TJ; Goldman R; Hopkins SC; Koblan KS; Kent J; Hsu J; Loebel A
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):80-89. PubMed ID: 30694697
[TBL] [Abstract][Full Text] [Related]
36. First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder.
Niederhofer H
J Diet Suppl; 2009; 6(4):342-6. PubMed ID: 22435515
[TBL] [Abstract][Full Text] [Related]
37. An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children.
Dave UP; Dingankar SR; Saxena VS; Joseph JA; Bethapudi B; Agarwal A; Kudiganti V
Adv Mind Body Med; 2014; 28(2):10-5. PubMed ID: 24682000
[TBL] [Abstract][Full Text] [Related]
38. Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial.
Golubchik P; Sever J; Weizman A
Clin Neuropharmacol; 2013; 36(2):37-41. PubMed ID: 23503544
[TBL] [Abstract][Full Text] [Related]
39. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
Durell TM; Adler LA; Williams DW; Deldar A; McGough JJ; Glaser PE; Rubin RL; Pigott TA; Sarkis EH; Fox BK
J Clin Psychopharmacol; 2013 Feb; 33(1):45-54. PubMed ID: 23277268
[TBL] [Abstract][Full Text] [Related]
40. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.
Weiss M; Hechtman L;
J Clin Psychiatry; 2006 Apr; 67(4):611-9. PubMed ID: 16669726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
